Durable Glycemic Benefits with Islet Transplantation in T1D |
Journal Updates
eMediNexus Coverage from: 
Durable Glycemic Benefits with Islet Transplantation in T1D
eMediNexus,  16 October 2019
remove_red_eye 499 Views
#Diabetes and Endocrinology #Pathology and Lab Medicine #Pharmacist #Transplantation

1 Read Comments                

Islet transplantation helped some patients with type 1 diabetes achieve long-lasting glycemic control, revealed a French study.

Ten-year outcomes for 28 patients who underwent allogeneic islet transplantation with the Edmonton protocol showed 28% free from insulin and maintaining HbA1c levels of ≤6.5%, reported Marie-Christine Vantyghem, MD, PhD of the University of Lille in France, and colleagues. Nearly 40% of these patients were able to achieve insulin independence with A1c ≤6.5% -- the studys primary endpoint -- only 5 years after islet transplantation, they wrote in Diabetes Care.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now